News

Any question ?

Please feel free to contact us. An expert is available Monday to Saturday, 9:00 am to 5:00 pm

Find out all our new releases

We will be present at various ophthalmology congresses. Contact us now to meet us!

🇧🇪 A First in Belgium for Retinal Imaging

We are proud to announce that CHU de Liège is the first institution in Belgium to own the new DREAM OCT by Intalight. We would like to warmly thank the ophthalmology team at the CHU de Liège for their trust, warm welcome, and strong investment in cutting-edge retinal imaging technology.

Read more

Glaucoma care is evolving, and precision is taking the lead.

ELIOS™ brings a refined approach to IOP reduction by working with the eye’s natural physiology, not against it. Using a cold excimer laser, ELIOS™ enhances trabecular outflow without implants, heat, or significant tissue disruption. It is a true tissue-sparing MIGS solution ! What makes ELIOS™ stand out :• Implant-free design that

Read more

✨ New Year = New Vision 👁️

2026: Seeing further, together A new year begins — and with it, new challenges and opportunities in ophthalmology:🔬 Technological innovation🤝 Meaningful collaborations🌍 Access to ever more advanced, high-quality solutions As we step into 2026, Medical DevEyes Belgium is proud to be part of this momentum:supporting innovative technologies, standing alongside our

Read more

✨🎄 Season’s Greetings from Medical DevEyes 🎄✨

As another year comes to an end, we would like to take a moment to thank our partners for their continued trust and collaboration. Working together with you is essential to our mission of supporting excellence in ophthalmic surgery, and we truly value the relationships we continue to build. We

Read more

Medical DevEyes Belgium @ OB 2025

We’re excited to announce that Medical DevEyes Belgium will be at Ophthalmologica Belgica 2025 from 26–28 November at the SQUARE Brussels Meeting Center — visit us at Stand Nº12! As the official Benelux distributor of Bausch & Lomb Surgery, we proudly represent a leading name in ophthalmic innovation.However, we also

Read more

REMARQUE À L'ATTENTION DE NOS VISITEURS

CE SITE CONTIENT DES INFORMATIONS RÉSERVÉES AUX PROFESSIONNELS

Les contenus de ce site n’ont pas été validés pour un usage grand public. Afin d’accéder à ces pages vous devez confirmer que vous êtes un professionnel.

Êtes-vous un professionnel?